| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.784 | 0.005 | 0.784 | Thioredoxin glutathione reductase inhibitor | 0.497 0.029 DBMET01009 | ||
| 0.767 | 0.004 | 0.767 | Immunosuppressant | 0.295 0.118 DBMET00630 0.344 0.09 DBMET02964 0.551 0.02 DBMET01010 0.518 0.028 DBMET02965 0.433 0.052 DBMET00771 0.535 0.024 DBMET00769 0.511 0.03 DBMET02966 0.5 0.033 DBMET02967 0.31 0.109 DBMET01007 | ||
| 0.656 | 0.007 | 0.656 | Immunomodulator | 0.533 0.019 DBMET01010 0.645 0.008 DBMET02965 0.266 0.103 DBMET00771 0.538 0.018 DBMET00769 0.329 0.067 DBMET02966 0.645 0.008 DBMET02967 0.192 0.174 DBMET01007 | ||
| 0.595 | 0.008 | 0.595 | Hypoxia-inducible factor 1 alpha inhibitor | 0.244 0.106 DBMET00630 0.186 0.171 DBMET02964 0.186 0.17 DBMET02965 | ||
| 0.482 | 0.045 | 0.612 | Prostaglandin dehydrogenase inhibitor | 0.224 0.142 DBMET00630 0.612 0.023 DBMET01009 | DBMET01009 | |
| 0.388 | 0.018 | 0.672 | EphB2 antagonist | 0.672 0.004 DBMET00630 0.599 0.005 DBMET02964 | DBMET00630 | |
| 0.336 | 0.009 | 0.737 | DNA polymerase I inhibitor | 0.465 0.004 DBMET00630 0.256 0.016 DBMET02964 0.547 0.003 DBMET01010 0.59 0.003 DBMET02965 0.317 0.01 DBMET00771 0.714 0.001 DBMET00769 0.42 0.005 DBMET02966 0.737 0.001 DBMET02967 0.656 0.002 DBMET01007 | DBMET02967 | |
| 0.244 | 0.019 | 0.325 | 5 Hydroxytryptamine 3E antagonist | 0.325 0.004 DBMET00630 0.321 0.004 DBMET02964 | DBMET00630 | |
| 0.232 | 0.008 | 0.897 | Antimetabolite | 0.178 0.01 DBMET00630 0.135 0.013 DBMET01009 0.08 0.019 DBMET02964 0.771 0.001 DBMET01010 0.691 0.002 DBMET02965 0.262 0.006 DBMET00771 0.897 0.001 DBMET00769 0.413 0.003 DBMET02966 0.871 0.001 DBMET02967 0.43 0.003 DBMET01007 | DBMET00769 | |
| 0.226 | 0.008 | 0.281 | Phosphodiesterase 7B inhibitor | 0.281 0.005 DBMET00630 0.104 0.052 DBMET02964 | DBMET00630 | |
| 0.344 | 0.143 | 0.344 | Apoptosis agonist | 0.266 0.198 DBMET02967 | ||
| 0.25 | 0.049 | 0.937 | RNA-directed DNA polymerase inhibitor | 0.347 0.024 DBMET00630 0.217 0.077 DBMET01009 0.354 0.023 DBMET02964 0.755 0.002 DBMET01010 0.703 0.002 DBMET02965 0.576 0.007 DBMET00771 0.937 0.001 DBMET00769 0.648 0.004 DBMET02966 0.903 0.001 DBMET02967 0.839 0.001 DBMET01007 | DBMET00769 | |
| 0.242 | 0.046 | 0.982 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.281 0.03 DBMET00630 0.307 0.021 DBMET01009 0.197 0.075 DBMET02964 0.875 0 DBMET01010 0.719 0.001 DBMET02965 0.582 0.003 DBMET00771 0.982 0 DBMET00769 0.571 0.003 DBMET02966 0.9 0 DBMET02967 0.629 0.002 DBMET01007 | DBMET00769 | |
| 0.215 | 0.018 | 0.258 | MAP kinase 12 inhibitor | 0.115 0.076 DBMET00630 0.258 0.011 DBMET02964 | DBMET02964 | |
| 0.228 | 0.038 | 0.228 | Histone acetyltransferase inhibitor | 0.19 0.085 DBMET00630 | ||
| 0.212 | 0.022 | 0.212 | Epidermal growth factor receptor kinase inhibitor | 0.141 0.054 DBMET00630 0.112 0.081 DBMET02964 0.155 0.045 DBMET01007 | ||
| 0.189 | 0.002 | 0.19 | AICAR transformylase inhibitor | 0.121 0.004 DBMET00630 0.064 0.012 DBMET02964 0.188 0.002 DBMET01010 0.188 0.002 DBMET02965 0.043 0.033 DBMET00771 0.19 0.002 DBMET00769 0.107 0.004 DBMET02966 0.19 0.002 DBMET02967 0.096 0.005 DBMET01007 | DBMET02967 | |
| 0.21 | 0.033 | 0.419 | c-Src kinase inhibitor | 0.419 0.006 DBMET00630 0.372 0.009 DBMET02964 | DBMET00630 | |
| 0.237 | 0.07 | 0.317 | Cyclic AMP phosphodiesterase inhibitor | 0.249 0.064 DBMET00630 0.302 0.041 DBMET02964 0.311 0.038 DBMET01010 0.317 0.036 DBMET02965 0.221 0.079 DBMET00769 0.228 0.075 DBMET02967 | DBMET02965 | |
| 0.23 | 0.083 | 0.927 | DNA synthesis inhibitor | 0.36 0.028 DBMET00630 0.198 0.126 DBMET01009 0.372 0.026 DBMET02964 0.782 0.003 DBMET01010 0.759 0.004 DBMET02965 0.395 0.022 DBMET00771 0.927 0.001 DBMET00769 0.582 0.008 DBMET02966 0.918 0.002 DBMET02967 0.811 0.003 DBMET01007 | DBMET00769 | |
| 0.167 | 0.034 | 0.167 | Antibacterial (Helicobacter pylori) | 0.144 0.051 DBMET00630 0.135 0.062 DBMET02964 | ||
| 0.151 | 0.023 | 0.151 | Epidermal growth factor antagonist | |||
| 0.148 | 0.021 | 0.148 | ErbB-4 antagonist | |||
| 0.156 | 0.03 | 0.483 | Bronchodilator | 0.483 0.005 DBMET00630 0.101 0.063 DBMET02964 | DBMET00630 | |
| 0.153 | 0.034 | 0.153 | MAP kinase 13 inhibitor | 0.135 0.044 DBMET02964 | ||
| 0.224 | 0.107 | 0.362 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.362 0.01 DBMET00630 0.221 0.113 DBMET02964 | DBMET00630 | |
| 0.12 | 0.019 | 0.346 | Adenosine A1 receptor antagonist | 0.239 0.009 DBMET00630 0.073 0.031 DBMET01009 0.127 0.019 DBMET02964 0.298 0.006 DBMET01010 0.346 0.005 DBMET02965 0.067 0.034 DBMET00771 0.174 0.013 DBMET00769 0.164 0.014 DBMET02966 0.21 0.01 DBMET02967 | DBMET02965 | |
| 0.194 | 0.096 | 0.194 | ErbB-1 antagonist | 0.172 0.13 DBMET02964 | ||
| 0.112 | 0.031 | 0.164 | Alpha 2d adrenoreceptor antagonist | 0.164 0.006 DBMET00630 0.155 0.008 DBMET02964 | DBMET00630 | |
| 0.079 | 0.004 | 0.901 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.104 0.002 DBMET00630 0.079 0.004 DBMET01009 0.077 0.005 DBMET02964 0.271 0 DBMET01010 0.182 0.001 DBMET02965 0.166 0.001 DBMET00771 0.901 0 DBMET00769 0.289 0 DBMET02966 0.386 0 DBMET02967 0.241 0 DBMET01007 | DBMET00769 | |
| 0.089 | 0.015 | 0.218 | Cyclin B1 inhibitor | 0.164 0.005 DBMET00630 0.218 0.004 DBMET02964 | DBMET02964 | |
| 0.118 | 0.048 | 0.366 | Xanthine oxidase inhibitor | 0.316 0.007 DBMET00630 0.366 0.005 DBMET01009 0.195 0.02 DBMET02964 0.086 0.079 DBMET01010 0.09 0.071 DBMET00769 | DBMET01009 | |
| 0.182 | 0.115 | 0.588 | Aldehyde oxidase inhibitor | 0.539 0.027 DBMET00630 0.588 0.021 DBMET02964 | DBMET02964 | |
| 0.08 | 0.015 | 0.191 | Cyclin B2 inhibitor | 0.155 0.005 DBMET00630 0.191 0.004 DBMET02964 | DBMET02964 | |
| 0.1 | 0.035 | 0.1 | ErbB-2 antagonist | |||
| 0.112 | 0.051 | 0.681 | Adenylate kinase inhibitor | 0.148 0.027 DBMET00630 0.112 0.051 DBMET01009 0.144 0.029 DBMET02964 0.594 0.001 DBMET01010 0.562 0.001 DBMET02965 0.364 0.004 DBMET00771 0.681 0 DBMET00769 0.36 0.004 DBMET02966 0.651 0 DBMET02967 0.454 0.002 DBMET01007 | DBMET00769 | |
| 0.077 | 0.017 | 0.182 | Cyclin B inhibitor | 0.146 0.005 DBMET00630 0.182 0.005 DBMET02964 | DBMET02964 | |
| 0.146 | 0.086 | 0.322 | Src kinase inhibitor | 0.322 0.022 DBMET00630 0.312 0.024 DBMET02964 | DBMET00630 | |
| 0.249 | 0.191 | 0.451 | MAP kinase kinase 6 inhibitor | 0.451 0.034 DBMET00630 | DBMET00630 | |
| 0.087 | 0.035 | 0.284 | Adenosine A3 receptor antagonist | 0.158 0.012 DBMET00630 0.078 0.047 DBMET01009 0.202 0.009 DBMET02964 0.136 0.014 DBMET01010 0.235 0.008 DBMET02965 0.079 0.045 DBMET00771 0.176 0.01 DBMET00769 0.11 0.022 DBMET02966 0.284 0.006 DBMET02967 | DBMET02967 | |
| 0.091 | 0.041 | 0.091 | MAP kinase 11 inhibitor | |||
| 0.065 | 0.017 | 0.889 | Adenosine deaminase inhibitor | 0.093 0.006 DBMET00630 0.092 0.007 DBMET02964 0.208 0.002 DBMET01010 0.327 0.001 DBMET02965 0.079 0.01 DBMET00771 0.642 0.001 DBMET00769 0.109 0.004 DBMET02966 0.889 0.001 DBMET02967 0.202 0.002 DBMET01007 | DBMET02967 | |
| 0.106 | 0.059 | 0.146 | Ephrin antagonist | 0.146 0.038 DBMET00630 0.102 0.061 DBMET02964 | DBMET00630 | |
| 0.065 | 0.034 | 0.323 | Phosphatidylinositol 3-kinase delta inhibitor | 0.323 0.005 DBMET00630 0.291 0.005 DBMET02964 | DBMET00630 | |
| 0.08 | 0.052 | 0.153 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.121 0.025 DBMET00630 0.153 0.013 DBMET02964 | DBMET02964 | |
| 0.027 | 0.004 | 0.076 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.076 0.001 DBMET00630 0.018 0.009 DBMET01009 0.066 0.001 DBMET02964 0.022 0.005 DBMET02966 0.026 0.004 DBMET01007 | DBMET00630 | |
| 0.086 | 0.063 | 0.857 | NADH dehydrogenase inhibitor | 0.295 0.007 DBMET00630 0.126 0.026 DBMET01009 0.258 0.008 DBMET02964 0.796 0.001 DBMET01010 0.782 0.001 DBMET02965 0.412 0.004 DBMET00771 0.857 0 DBMET00769 0.33 0.006 DBMET02966 0.845 0 DBMET02967 0.592 0.002 DBMET01007 | DBMET00769 | |
| 0.037 | 0.017 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.03 0.023 DBMET00630 | ||
| 0.134 | 0.115 | 0.223 | LIM domain kinase 1 inhibitor | 0.223 0.052 DBMET00630 0.217 0.055 DBMET02964 | DBMET00630 | |
| 0.061 | 0.044 | 0.184 | Adenosine A2a receptor antagonist | 0.184 0.011 DBMET00630 0.113 0.022 DBMET02964 0.098 0.025 DBMET01010 0.119 0.02 DBMET02965 0.064 0.041 DBMET00769 0.077 0.033 DBMET02966 0.08 0.032 DBMET02967 | DBMET00630 | |
| 0.095 | 0.081 | 0.113 | EphA2 antagonist | 0.106 0.069 DBMET00630 0.113 0.062 DBMET02964 | DBMET02964 | |
| 0.098 | 0.087 | 0.148 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.148 0.048 DBMET00630 0.129 0.061 DBMET02964 | DBMET00630 | |
| 0.152 | 0.142 | 0.253 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.253 0.059 DBMET00630 | DBMET00630 | |
| 0.097 | 0.088 | 0.148 | Abl kinase inhibitor | 0.148 0.048 DBMET00630 0.128 0.061 DBMET02964 | DBMET00630 | |
| 0.108 | 0.101 | 0.5 | DNA repair enzyme inhibitor | 0.15 0.031 DBMET00630 0.154 0.028 DBMET01009 0.152 0.03 DBMET02964 0.5 0.002 DBMET01010 0.455 0.003 DBMET02965 0.122 0.068 DBMET00771 0.235 0.006 DBMET00769 0.171 0.017 DBMET02966 0.208 0.008 DBMET02967 0.18 0.013 DBMET01007 | DBMET01010 | |
| 0.057 | 0.051 | 0.201 | Adenosine A2 receptor antagonist | 0.201 0.01 DBMET00630 0.114 0.023 DBMET02964 0.129 0.02 DBMET01010 0.154 0.016 DBMET02965 0.074 0.038 DBMET00769 0.127 0.02 DBMET02966 0.091 0.03 DBMET02967 | DBMET00630 | |
| 0.075 | 0.068 | 0.075 | ErbB-3 antagonist | |||
| 0.021 | 0.016 | 0.059 | Alpha 2d adrenoreceptor agonist | 0.059 0.004 DBMET00630 0.046 0.005 DBMET02964 | DBMET00630 | |
| 0.008 | 0.004 | 0.008 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 DBMET02964 | ||
| 0.037 | 0.037 | 0.772 | Thymidine kinase inhibitor | 0.085 0.008 DBMET00630 0.038 0.033 DBMET01009 0.086 0.008 DBMET02964 0.39 0.002 DBMET01010 0.309 0.002 DBMET02965 0.08 0.009 DBMET00771 0.772 0.001 DBMET00769 0.092 0.007 DBMET02966 0.722 0.001 DBMET02967 0.771 0.001 DBMET01007 | DBMET00769 | |
| 0.072 | 0.074 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 DBMET00630 0.091 0.024 DBMET02964 | DBMET00630 | |
| 0.065 | 0.073 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.101 0.013 DBMET00630 0.087 0.026 DBMET02964 0.084 0.03 DBMET02966 | DBMET00630 | |
| 0.042 | 0.05 | 0.056 | Histamine H4 receptor antagonist | 0.056 0.022 DBMET00630 0.05 0.031 DBMET02964 | DBMET00630 | |
| 0.048 | 0.057 | 0.622 | Biliverdin reductase inhibitor | 0.086 0.023 DBMET00630 0.052 0.051 DBMET01009 0.074 0.029 DBMET02964 0.575 0.001 DBMET01010 0.555 0.001 DBMET02965 0.194 0.006 DBMET00771 0.622 0.001 DBMET00769 0.145 0.01 DBMET02966 0.602 0.001 DBMET02967 0.303 0.003 DBMET01007 | DBMET00769 | |
| 0.008 | 0.018 | 0.139 | Purine nucleoside phosphorylase inhibitor | 0.016 0.004 DBMET00630 0.014 0.005 DBMET01009 0.04 0.002 DBMET02964 0.036 0.002 DBMET01010 0.022 0.003 DBMET02965 0.017 0.004 DBMET00771 0.139 0.001 DBMET00769 0.063 0.002 DBMET02966 0.066 0.002 DBMET02967 0.044 0.002 DBMET01007 | DBMET00769 | |
| 0.011 | 0.023 | 0.056 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.038 0.004 DBMET01010 0.033 0.004 DBMET02965 0.032 0.004 DBMET00771 0.056 0.004 DBMET00769 0.037 0.004 DBMET02966 0.048 0.004 DBMET02967 | DBMET00769 | |
| 0.057 | 0.069 | 0.098 | Protein kinase B alpha inhibitor | 0.098 0.031 DBMET00630 0.074 0.045 DBMET02964 | DBMET00630 | |
| 0.03 | 0.043 | 0.139 | Alpha 1d adrenoreceptor agonist | 0.089 0.004 DBMET00630 0.139 0.002 DBMET02964 | DBMET02964 | |
| 0.047 | 0.061 | 0.795 | Carbamoyl phosphate synthetase inhibitor | 0.127 0.014 DBMET00630 0.056 0.047 DBMET01009 0.114 0.017 DBMET02964 0.692 0.001 DBMET01010 0.678 0.001 DBMET02965 0.451 0.003 DBMET00771 0.795 0 DBMET00769 0.458 0.003 DBMET02966 0.784 0 DBMET02967 0.515 0.002 DBMET01007 | DBMET00769 | |
| 0.043 | 0.058 | 0.171 | Alpha 1b adrenoreceptor agonist | 0.086 0.007 DBMET00630 0.171 0.003 DBMET02964 | DBMET02964 | |
| 0.068 | 0.083 | 0.123 | Histamine N-methyltransferase inhibitor | 0.11 0.038 DBMET00630 0.123 0.028 DBMET02964 | DBMET02964 | |
| 0.047 | 0.064 | 0.083 | Phosphodiesterase VII inhibitor | 0.083 0.023 DBMET00630 | DBMET00630 | |
| 0.013 | 0.03 | 0.994 | Adenosine kinase inhibitor | 0.028 0.011 DBMET00630 0.603 0.001 DBMET01010 0.508 0.001 DBMET02965 0.07 0.005 DBMET00771 0.994 0 DBMET00769 0.11 0.003 DBMET02966 0.985 0 DBMET02967 0.098 0.003 DBMET01007 | DBMET00769 | |
| 0.101 | 0.12 | 0.129 | CDC-like kinase 1 inhibitor | 0.129 0.087 DBMET02964 | DBMET02964 | |
| 0.023 | 0.043 | 0.028 | DNA polymerase III inhibitor | 0.028 0.019 DBMET01007 | DBMET01007 | |
| 0.011 | 0.032 | 0.286 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET02964 0.167 0 DBMET01010 0.193 0 DBMET02965 0.047 0.002 DBMET00771 0.235 0 DBMET00769 0.074 0.001 DBMET02966 0.286 0 DBMET02967 0.054 0.002 DBMET01007 | DBMET02967 | |
| 0.015 | 0.036 | 0.43 | Purinergic P2X agonist | 0.188 0.002 DBMET01010 0.19 0.002 DBMET02965 0.095 0.003 DBMET00771 0.43 0.001 DBMET00769 0.092 0.004 DBMET02966 0.427 0.001 DBMET02967 0.178 0.002 DBMET01007 | DBMET00769 | |
| 0.02 | 0.045 | 0.041 | Complement factor 1s inhibitor | 0.028 0.011 DBMET00630 0.041 0.004 DBMET02964 | DBMET02964 | |
| 0.057 | 0.082 | 0.914 | Glutamate dehydrogenase inhibitor | 0.098 0.032 DBMET00630 0.068 0.059 DBMET01009 0.085 0.04 DBMET02964 0.833 0.001 DBMET01010 0.749 0.002 DBMET02965 0.225 0.008 DBMET00771 0.914 0 DBMET00769 0.374 0.004 DBMET02966 0.876 0.001 DBMET02967 0.558 0.003 DBMET01007 | DBMET00769 | |
| 0.039 | 0.065 | 0.827 | Argininosuccinate synthase inhibitor | 0.085 0.023 DBMET00630 0.073 0.029 DBMET02964 0.606 0.001 DBMET01010 0.554 0.001 DBMET02965 0.135 0.013 DBMET00771 0.827 0 DBMET00769 0.229 0.006 DBMET02966 0.808 0.001 DBMET02967 0.393 0.003 DBMET01007 | DBMET00769 | |
| 0.017 | 0.043 | 0.101 | Histamine H3 receptor agonist | 0.101 0.006 DBMET00630 0.073 0.008 DBMET02964 | DBMET00630 | |
| 0.201 | 0.227 | 0.43 | Transcription factor inhibitor | 0.43 0.098 DBMET01009 | DBMET01009 | |
| 0.034 | 0.061 | 0.048 | Farnesyltransferase inhibitor | 0.048 0.03 DBMET00769 | DBMET00769 | |
| 0.033 | 0.063 | 0.879 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET00630 0.067 0.027 DBMET02964 0.716 0.001 DBMET01010 0.612 0.002 DBMET02965 0.216 0.006 DBMET00771 0.879 0.001 DBMET00769 0.382 0.003 DBMET02966 0.846 0.001 DBMET02967 0.433 0.003 DBMET01007 | DBMET00769 | |
| 0.031 | 0.064 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 DBMET00630 0.05 0.025 DBMET02964 | DBMET02964 | |
| 0.011 | 0.044 | 0.061 | Adenosine A3 receptor agonist | 0.061 0.004 DBMET01010 0.06 0.004 DBMET02965 0.049 0.004 DBMET00771 0.056 0.004 DBMET00769 0.053 0.004 DBMET02966 0.055 0.004 DBMET02967 0.02 0.009 DBMET01007 | DBMET01010 | |
| 0.019 | 0.053 | 0.1 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET00630 0.029 0.014 DBMET01009 0.1 0.003 DBMET01010 0.095 0.003 DBMET02965 0.075 0.004 DBMET00771 0.03 0.012 DBMET00769 0.037 0.008 DBMET02966 0.029 0.014 DBMET02967 0.029 0.013 DBMET01007 | DBMET01010 | |
| 0.033 | 0.07 | 0.06 | Histamine H1 receptor agonist | 0.06 0.008 DBMET00630 0.056 0.011 DBMET02964 | DBMET00630 | |
| 0.08 | 0.121 | 0.119 | Multidrug resistance-associated protein 1 inhibitor | 0.119 0.049 DBMET00630 0.094 0.089 DBMET02964 | DBMET00630 | |
| 0.009 | 0.05 | 0.019 | Histamine H4 receptor agonist | 0.019 0.012 DBMET00630 | DBMET00630 | |
| 0.011 | 0.053 | 0.238 | Adenosine A1 receptor agonist | 0.238 0.003 DBMET01010 0.231 0.003 DBMET02965 0.099 0.004 DBMET00771 0.218 0.003 DBMET00769 0.099 0.004 DBMET02966 0.212 0.003 DBMET02967 0.04 0.007 DBMET01007 | DBMET01010 | |
| 0.032 | 0.077 | 0.37 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 DBMET00630 0.081 0.022 DBMET02964 0.307 0.001 DBMET01010 0.308 0.001 DBMET02965 0.134 0.011 DBMET00771 0.368 0 DBMET00769 0.149 0.009 DBMET02966 0.37 0 DBMET02967 0.233 0.004 DBMET01007 | DBMET02967 | |
| 0.009 | 0.057 | 0.024 | CDK2/cyclin A3 inhibitor | 0.019 0.006 DBMET00630 0.024 0.004 DBMET02964 | DBMET02964 | |
| 0.013 | 0.062 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 DBMET02964 | DBMET02964 | |
| 0.018 | 0.068 | 0.041 | Purinergic P2Y15 antagonist | 0.035 0.01 DBMET00630 0.033 0.013 DBMET02964 0.036 0.009 DBMET01010 0.034 0.012 DBMET02965 0.036 0.009 DBMET00771 0.041 0.006 DBMET00769 0.041 0.006 DBMET02966 0.039 0.008 DBMET02967 | DBMET02966 | |
| 0.012 | 0.067 | 0.063 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET00630 0.017 0.015 DBMET02964 0.043 0.001 DBMET01010 0.043 0.001 DBMET02965 0.021 0.007 DBMET00771 0.062 0 DBMET00769 0.022 0.006 DBMET02966 0.063 0 DBMET02967 0.032 0.002 DBMET01007 | DBMET02967 | |
| 0.012 | 0.073 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | 0.024 0.011 DBMET00630 0.022 0.014 DBMET02964 | DBMET00630 | |
| 0.11 | 0.171 | 0.276 | MAP kinase 3 inhibitor | 0.276 0.005 DBMET00630 0.201 0.023 DBMET02964 | DBMET00630 | |
| 0.007 | 0.07 | 0.062 | Adenosine A2 receptor agonist | 0.038 0.004 DBMET01010 0.062 0.003 DBMET02965 0.016 0.011 DBMET00771 0.025 0.006 DBMET00769 0.024 0.006 DBMET02966 0.035 0.005 DBMET02967 | DBMET02965 | |
| 0.054 | 0.12 | 0.249 | Cyclin-dependent kinase 1 inhibitor | 0.245 0.018 DBMET00630 0.249 0.018 DBMET02964 | DBMET02964 | |
| 0.033 | 0.099 | 0.868 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.104 0.013 DBMET00630 0.072 0.024 DBMET01009 0.076 0.022 DBMET02964 0.701 0 DBMET01010 0.58 0.001 DBMET02965 0.312 0.003 DBMET00771 0.868 0 DBMET00769 0.42 0.002 DBMET02966 0.778 0 DBMET02967 0.627 0.001 DBMET01007 | DBMET00769 | |
| 0.035 | 0.103 | 0.907 | Phosphofructokinase-1 inhibitor | 0.081 0.04 DBMET00630 0.07 0.048 DBMET02964 0.732 0.001 DBMET01010 0.645 0.001 DBMET02965 0.245 0.008 DBMET00771 0.907 0 DBMET00769 0.3 0.005 DBMET02966 0.856 0 DBMET02967 0.434 0.003 DBMET01007 | DBMET00769 | |
| 0.024 | 0.096 | 0.059 | Adenosine A2b receptor antagonist | 0.057 0.026 DBMET00630 0.059 0.025 DBMET02964 | DBMET02964 | |
| 0.005 | 0.078 | 0.274 | Purinergic P2Y2 agonist | 0.041 0.001 DBMET01010 0.092 0 DBMET02965 0.015 0.003 DBMET00771 0.098 0 DBMET00769 0.013 0.005 DBMET02966 0.274 0 DBMET02967 0.027 0.001 DBMET01007 | DBMET02967 | |
| 0.033 | 0.106 | 0.083 | Cyclin A2 inhibitor | 0.083 0.031 DBMET02964 | DBMET02964 | |
| 0.004 | 0.078 | 0.012 | Egl nine homolog 2 inhibitor | 0.012 0.008 DBMET00630 | DBMET00630 | |
| 0.003 | 0.077 | 0.601 | Purinergic P2 agonist | 0.133 0.001 DBMET01010 0.132 0.001 DBMET02965 0.054 0.003 DBMET00771 0.601 0.001 DBMET00769 0.044 0.003 DBMET02966 0.578 0.001 DBMET02967 0.146 0.001 DBMET01007 | DBMET00769 | |
| 0.003 | 0.077 | 0.601 | Purinergic receptor agonist | 0.133 0.001 DBMET01010 0.132 0.001 DBMET02965 0.054 0.003 DBMET00771 0.601 0.001 DBMET00769 0.044 0.003 DBMET02966 0.578 0.001 DBMET02967 0.146 0.001 DBMET01007 | DBMET00769 | |
| 0.003 | 0.08 | 0.596 | Purinergic P2Y agonist | 0.123 0.001 DBMET01010 0.122 0.001 DBMET02965 0.046 0.003 DBMET00771 0.596 0.001 DBMET00769 0.037 0.003 DBMET02966 0.572 0.001 DBMET02967 0.135 0.001 DBMET01007 | DBMET00769 | |
| 0.005 | 0.083 | 0.01 | CXC chemokine 3 receptor agonist | 0.01 0.007 DBMET00630 | DBMET00630 | |
| 0.078 | 0.157 | 0.17 | Tyrosine kinase inhibitor | 0.17 0.08 DBMET00630 | DBMET00630 | |
| 0.01 | 0.091 | 0.07 | Alpha 1a adrenoreceptor agonist | 0.03 0.01 DBMET00630 0.07 0.004 DBMET02964 | DBMET02964 | |
| 0.022 | 0.103 | 0.069 | Histamine H2 receptor agonist | 0.069 0.01 DBMET00630 0.066 0.012 DBMET02964 | DBMET00630 | |
| 0.061 | 0.143 | 0.105 | Cyclin-dependent kinase 9 inhibitor | 0.105 0.057 DBMET02964 | DBMET02964 | |
| 0.048 | 0.131 | 0.413 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.413 0.005 DBMET00630 0.22 0.015 DBMET02964 | DBMET00630 | |
| 0.169 | 0.253 | 0.506 | GABA C receptor rho-3 antagonist | 0.506 0.024 DBMET00630 0.231 0.172 DBMET01009 0.413 0.056 DBMET02964 | DBMET00630 | |
| 0.029 | 0.113 | 0.072 | Cyclin A inhibitor | 0.072 0.036 DBMET02964 | DBMET02964 | |
| 0.007 | 0.092 | 0.036 | Adenosine A2b receptor agonist | 0.036 0.003 DBMET01010 0.035 0.003 DBMET02965 0.031 0.003 DBMET00771 0.031 0.003 DBMET00769 0.031 0.003 DBMET02966 0.03 0.004 DBMET02967 0.013 0.012 DBMET01007 | DBMET01010 | |
| 0.054 | 0.141 | 0.72 | Alcohol dehydrogenase inhibitor | 0.187 0.014 DBMET00630 0.12 0.035 DBMET01009 0.642 0.002 DBMET01010 0.282 0.005 DBMET02965 0.129 0.029 DBMET00771 0.72 0.001 DBMET00769 0.327 0.005 DBMET02966 0.429 0.004 DBMET02967 | DBMET00769 | |
| 0.036 | 0.126 | 0.619 | Purinergic P2X1 antagonist | 0.068 0.034 DBMET00630 0.061 0.042 DBMET01009 0.087 0.021 DBMET02964 0.51 0 DBMET01010 0.53 0 DBMET02965 0.264 0.002 DBMET00771 0.593 0 DBMET00769 0.201 0.004 DBMET02966 0.619 0 DBMET02967 0.271 0.002 DBMET01007 | DBMET02967 | |
| 0.024 | 0.118 | 0.374 | Raf kinase B inhibitor | 0.374 0.005 DBMET00630 0.167 0.012 DBMET02964 | DBMET00630 | |
| 0.004 | 0.103 | 0.049 | Adenosine A2a receptor agonist | 0.013 0.012 DBMET02964 0.04 0.004 DBMET01010 0.049 0.003 DBMET02965 0.016 0.009 DBMET00771 0.03 0.005 DBMET00769 0.03 0.005 DBMET02966 0.039 0.004 DBMET02967 | DBMET02965 | |
| 0.018 | 0.118 | 0.122 | Geranyltranstransferase inhibitor | 0.041 0.036 DBMET00630 0.051 0.021 DBMET02964 0.057 0.016 DBMET02965 0.079 0.005 DBMET00769 0.122 0.003 DBMET02967 | DBMET02967 | |
| 0.034 | 0.135 | 0.257 | CDK1/cyclin B1 inhibitor | 0.227 0.006 DBMET00630 0.257 0.005 DBMET02964 | DBMET02964 | |
| 0.014 | 0.116 | 0.032 | MAP3K8 inhibitor | 0.032 0.014 DBMET00630 0.031 0.016 DBMET02964 | DBMET00630 | |
| 0.012 | 0.114 | 0.567 | Phosphoglycerate kinase inhibitor | 0.47 0.001 DBMET01010 0.452 0.001 DBMET02965 0.147 0.004 DBMET00771 0.567 0 DBMET00769 0.383 0.002 DBMET02966 0.556 0 DBMET02967 0.265 0.003 DBMET01007 | DBMET00769 | |
| 0.009 | 0.117 | 0.025 | Complement factor 1 inhibitor | 0.025 0.005 DBMET02964 | DBMET02964 | |
| 0.012 | 0.12 | 0.892 | Fumarate hydratase inhibitor | 0.737 0.001 DBMET01010 0.7 0.001 DBMET02965 0.061 0.01 DBMET00771 0.892 0 DBMET00769 0.091 0.006 DBMET02966 0.878 0 DBMET02967 0.203 0.003 DBMET01007 | DBMET00769 | |
| 0.028 | 0.141 | 0.123 | Phosphatidylinositol kinase inhibitor | 0.123 0.016 DBMET00630 0.075 0.03 DBMET02964 | DBMET00630 | |
| 0.03 | 0.144 | 0.367 | Raf kinase inhibitor | 0.367 0.005 DBMET00630 0.17 0.016 DBMET02964 | DBMET00630 | |
| 0.053 | 0.17 | 0.29 | GABA C receptor agonist | 0.29 0.01 DBMET00630 0.12 0.05 DBMET01009 0.254 0.013 DBMET02964 | DBMET00630 | |
| 0.052 | 0.17 | 0.649 | UDP-glucose 4-epimerase inhibitor | 0.097 0.064 DBMET00630 0.087 0.078 DBMET02964 0.571 0.001 DBMET01010 0.558 0.002 DBMET02965 0.196 0.019 DBMET00771 0.649 0.001 DBMET00769 0.138 0.034 DBMET02966 0.637 0.001 DBMET02967 0.421 0.005 DBMET01007 | DBMET00769 | |
| 0.019 | 0.138 | 0.036 | Somatostatin 4 agonist | 0.036 0.028 DBMET00630 | DBMET00630 | |
| 0.005 | 0.125 | 0.035 | Alpha 2c adrenoreceptor agonist | 0.022 0.009 DBMET00630 0.035 0.004 DBMET02964 | DBMET02964 | |
| 0.079 | 0.2 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.053 DBMET02964 | DBMET02964 | |
| 0.052 | 0.179 | 0.219 | Protein-tyrosine kinase Lyn inhibitor | 0.219 0.039 DBMET00630 0.169 0.057 DBMET02964 | DBMET00630 | |
| 0.029 | 0.162 | 0.056 | Carbonic anhydrase II stimulant | 0.056 0.029 DBMET00630 0.053 0.034 DBMET02964 | DBMET00630 | |
| 0.035 | 0.168 | 0.155 | Protein kinase B beta inhibitor | 0.134 0.01 DBMET00630 0.155 0.007 DBMET02964 | DBMET02964 | |
| 0.017 | 0.151 | 0.309 | Xanthine dehydrogenase inhibitor | 0.063 0.036 DBMET00630 0.309 0.003 DBMET01009 | DBMET01009 | |
| 0.005 | 0.141 | 0.02 | Hexokinase stimulant | 0.02 0.014 DBMET02964 | DBMET02964 | |
| 0.01 | 0.146 | 0.035 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.035 0.004 DBMET00630 0.03 0.004 DBMET02964 | DBMET00630 | |
| 0.019 | 0.16 | 0.031 | Transforming growth factor beta 2 antagonist | 0.031 0.029 DBMET00630 | DBMET00630 | |
| 0 | 0.149 | 0.032 | Purinergic P2Y6 agonist | 0.011 0.001 DBMET01010 0.016 0 DBMET02965 0.019 0 DBMET00769 0.032 0 DBMET02967 0.006 0.001 DBMET01007 | DBMET02967 | |
| 0.039 | 0.189 | 0.124 | Protein kinase (CK2) alpha inhibitor | 0.124 0.059 DBMET00630 0.099 0.077 DBMET02964 | DBMET00630 | |
| 0.016 | 0.167 | 0.088 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.037 0.006 DBMET00630 0.039 0.005 DBMET02964 0.088 0.003 DBMET01010 0.079 0.003 DBMET02965 0.036 0.006 DBMET00769 0.035 0.007 DBMET02967 0.047 0.004 DBMET01007 | DBMET01010 | |
| 0.021 | 0.174 | 0.051 | Histamine agonist | 0.051 0.038 DBMET00630 | DBMET00630 | |
| 0.017 | 0.172 | 0.036 | ATR kinase inhibitor | 0.033 0.023 DBMET00630 0.036 0.017 DBMET02964 | DBMET02964 | |
| 0.047 | 0.203 | 0.427 | Phosphodiesterase I inhibitor | 0.095 0.051 DBMET00630 0.295 0.005 DBMET01010 0.182 0.013 DBMET02965 0.427 0.003 DBMET00769 0.307 0.005 DBMET02967 0.219 0.009 DBMET01007 | DBMET00769 | |
| 0.052 | 0.209 | 0.241 | Ribosomal protein S6 kinase inhibitor | 0.224 0.028 DBMET00630 0.241 0.023 DBMET02964 | DBMET02964 | |
| 0.042 | 0.201 | 0.158 | RET inhibitor | 0.158 0.057 DBMET00630 0.139 0.067 DBMET02964 | DBMET00630 | |
| 0.058 | 0.221 | 0.952 | Cytidine deaminase inhibitor | 0.148 0.077 DBMET00630 0.44 0.008 DBMET01009 0.928 0.001 DBMET01010 0.693 0.003 DBMET02965 0.388 0.011 DBMET00771 0.952 0.001 DBMET00769 0.286 0.021 DBMET02966 0.72 0.003 DBMET02967 0.641 0.004 DBMET01007 | DBMET00769 | |
| 0.029 | 0.192 | 0.07 | CYP2A6 inhibitor | 0.07 0.059 DBMET02964 | DBMET02964 | |
| 0.059 | 0.222 | 0.124 | Activin receptor-like kinase 2 inhibitor | 0.124 0.092 DBMET02964 | DBMET02964 | |
| 0.057 | 0.223 | 0.107 | mTOR complex 1 inhibitor | 0.101 0.06 DBMET00630 0.107 0.048 DBMET02964 | DBMET02964 | |
| 0.051 | 0.219 | 0.099 | Electrolyte absorption antagonist | 0.087 0.08 DBMET00630 0.099 0.059 DBMET02964 | DBMET02964 | |
| 0.024 | 0.193 | 0.074 | Histidine decarboxylase inhibitor | 0.074 0.047 DBMET00630 0.062 0.06 DBMET02964 | DBMET00630 | |
| 0.013 | 0.189 | 0.092 | Thymidylate synthase inhibitor | 0.092 0.005 DBMET01010 0.088 0.005 DBMET02965 0.05 0.028 DBMET00769 0.047 0.032 DBMET02966 0.046 0.033 DBMET02967 0.061 0.017 DBMET01007 | DBMET01010 | |
| 0.109 | 0.286 | 0.898 | Heat shock protein 70 antagonist | 0.129 0.127 DBMET00630 0.144 0.061 DBMET02964 0.278 0.004 DBMET01010 0.511 0.002 DBMET02965 0.758 0.001 DBMET00769 0.898 0.001 DBMET02967 0.162 0.026 DBMET01007 | DBMET02967 | |
| 0.03 | 0.211 | 0.056 | Phosphodiesterase 1A inhibitor | 0.056 0.053 DBMET00630 | DBMET00630 | |
| 0.057 | 0.239 | 0.184 | Clk dual-specificity kinase inhibitor | 0.132 0.131 DBMET00630 0.184 0.089 DBMET02964 | DBMET02964 | |
| 0.016 | 0.204 | 0.089 | Alcohol oxidase inhibitor | 0.089 0.021 DBMET00630 0.052 0.043 DBMET02964 | DBMET00630 | |
| 0.122 | 0.31 | 0.816 | DNA directed DNA polymerase inhibitor | 0.469 0.092 DBMET01009 0.648 0.044 DBMET01010 0.592 0.057 DBMET02965 0.26 0.185 DBMET00771 0.816 0.017 DBMET00769 0.774 0.023 DBMET02967 0.489 0.086 DBMET01007 | DBMET00769 | |
| 0.026 | 0.221 | 0.081 | Sirtuin 1 inhibitor | 0.081 0.034 DBMET00630 | DBMET00630 | |
| 0.022 | 0.217 | 0.07 | Dopamine beta hydroxylase inhibitor | 0.07 0.008 DBMET00630 0.055 0.022 DBMET01009 | DBMET00630 | |
| 0.018 | 0.213 | 0.097 | Alpha 2 adrenoreceptor agonist | 0.056 0.048 DBMET00630 0.097 0.016 DBMET02964 | DBMET02964 | |
| 0.025 | 0.221 | 0.089 | MAP3K7 inhibitor | 0.083 0.036 DBMET00630 0.089 0.03 DBMET02964 | DBMET02964 | |
| 0.117 | 0.313 | 0.842 | Vasodilator, coronary | 0.201 0.181 DBMET02964 0.477 0.019 DBMET01010 0.515 0.014 DBMET02965 0.223 0.16 DBMET00771 0.799 0.004 DBMET00769 0.265 0.12 DBMET02966 0.842 0.003 DBMET02967 0.303 0.085 DBMET01007 | DBMET02967 | |
| 0.046 | 0.242 | 0.115 | MAP kinase kinase 1 inhibitor | 0.103 0.053 DBMET00630 0.115 0.04 DBMET02964 | DBMET02964 | |
| 0.027 | 0.224 | 0.151 | Protein kinase (CK2) inhibitor | 0.151 0.032 DBMET00630 0.118 0.05 DBMET02964 | DBMET00630 | |
| 0.014 | 0.221 | 0.135 | CDK1/cyclin B inhibitor | 0.104 0.023 DBMET00630 0.135 0.015 DBMET02964 | DBMET02964 | |
| 0.093 | 0.305 | 0.227 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.19 0.083 DBMET00630 0.227 0.054 DBMET02964 | DBMET02964 | |
| 0.059 | 0.271 | 0.175 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.175 0.109 DBMET00630 0.163 0.119 DBMET02964 | DBMET00630 | |
| 0.036 | 0.252 | 0.222 | Lck kinase inhibitor | 0.125 0.081 DBMET00630 0.222 0.032 DBMET02964 | DBMET02964 | |
| 0.126 | 0.343 | 0.545 | Antibacterial | 0.261 0.167 DBMET00630 0.289 0.143 DBMET01009 0.545 0.03 DBMET01010 0.511 0.037 DBMET02965 0.48 0.046 DBMET00771 0.438 0.061 DBMET00769 0.488 0.044 DBMET02966 0.391 0.081 DBMET02967 0.329 0.115 DBMET01007 | DBMET01010 | |
| 0.069 | 0.29 | 0.459 | DNA methylase inhibitor | 0.36 0.015 DBMET01010 0.396 0.011 DBMET02965 0.42 0.01 DBMET00769 0.459 0.008 DBMET02967 | DBMET02967 | |
| 0.035 | 0.256 | 0.084 | Creatine kinase inhibitor | 0.084 0.08 DBMET00630 | DBMET00630 | |
| 0.045 | 0.268 | 0.748 | Adenylate cyclase inhibitor | 0.146 0.048 DBMET02964 0.619 0.003 DBMET01010 0.642 0.003 DBMET02965 0.168 0.035 DBMET00771 0.727 0.001 DBMET00769 0.296 0.014 DBMET02966 0.748 0.001 DBMET02967 0.412 0.007 DBMET01007 | DBMET02967 | |
| 0.014 | 0.239 | 0.07 | Janus tyrosine kinase 3 inhibitor | 0.07 0.052 DBMET02964 | DBMET02964 | |
| 0.006 | 0.239 | 0.023 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 DBMET00630 0.018 0.014 DBMET02964 | DBMET00630 | |
| 0.016 | 0.251 | 0.068 | CDC7 inhibitor | 0.068 0.046 DBMET00630 | DBMET00630 | |
| 0.019 | 0.255 | 0.118 | Porphobilinogen synthase inhibitor | 0.102 0.035 DBMET00630 0.118 0.029 DBMET02964 | DBMET02964 | |
| 0.017 | 0.256 | 0.054 | mTOR inhibitor | 0.054 0.034 DBMET02964 | DBMET02964 | |
| 0.182 | 0.421 | 0.422 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.422 0.082 DBMET00630 0.396 0.104 DBMET02964 | DBMET00630 | |
| 0.043 | 0.283 | 0.087 | mTOR complex 2 inhibitor | 0.087 0.053 DBMET00630 0.083 0.062 DBMET02964 | DBMET00630 | |
| 0.025 | 0.268 | 0.142 | MAP kinase kinase kinase inhibitor | 0.142 0.039 DBMET00630 0.117 0.052 DBMET02964 | DBMET00630 | |
| 0.025 | 0.268 | 0.111 | Cyclin-dependent kinase 5 inhibitor | 0.111 0.066 DBMET00630 | DBMET00630 | |
| 0.033 | 0.277 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.063 0.042 DBMET00630 0.059 0.053 DBMET02964 | DBMET00630 | |
| 0.053 | 0.298 | 0.172 | Dyrk kinase inhibitor | 0.172 0.116 DBMET00630 0.172 0.116 DBMET02964 | DBMET02964 | |
| 0.035 | 0.282 | 0.176 | Alkylator | 0.124 0.064 DBMET02964 0.145 0.049 DBMET01010 0.176 0.034 DBMET02965 0.134 0.056 DBMET00769 0.164 0.04 DBMET02967 0.1 0.088 DBMET01007 | DBMET02965 | |
| 0.024 | 0.275 | 0.096 | CDK/cyclin complex inhibitor | 0.096 0.055 DBMET02964 | DBMET02964 | |
| 0.024 | 0.278 | 0.075 | Heat shock protein 90 beta antagonist | 0.075 0.024 DBMET02964 | DBMET02964 | |
| 0.038 | 0.293 | 0.158 | GABA C receptor rho-1 antagonist | 0.158 0.018 DBMET00630 0.12 0.04 DBMET02964 | DBMET00630 | |
| 0.1 | 0.361 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.097 DBMET00630 0.133 0.103 DBMET02964 | DBMET00630 | |
| 0.032 | 0.295 | 0.125 | Ferrochelatase inhibitor | 0.125 0.051 DBMET00630 0.105 0.065 DBMET02964 | DBMET00630 | |
| 0.047 | 0.311 | 0.824 | Aldehyde dehydrogenase inhibitor | 0.116 0.075 DBMET00630 0.137 0.056 DBMET02964 0.61 0.004 DBMET01010 0.637 0.003 DBMET02965 0.804 0.002 DBMET00769 0.824 0.002 DBMET02967 0.16 0.042 DBMET01007 | DBMET02967 | |
| 0.031 | 0.296 | 0.09 | Exportin-1 inhibitor | 0.09 0.015 DBMET00630 0.076 0.031 DBMET02964 | DBMET00630 | |
| 0.025 | 0.295 | 0.095 | Interferon agonist | 0.095 0.033 DBMET01009 | DBMET01009 | |
| 0.033 | 0.306 | 0.137 | MAP kinase kinase inhibitor | 0.137 0.059 DBMET02964 | DBMET02964 | |
| 0.025 | 0.304 | 0.34 | Glycogen synthase kinase-3 inhibitor | 0.34 0.012 DBMET00630 | DBMET00630 | |
| 0.037 | 0.317 | 0.165 | CDC-like kinase 4 inhibitor | 0.165 0.089 DBMET02964 | DBMET02964 | |
| 0.022 | 0.305 | 0.172 | CDK2/cyclin A inhibitor | 0.145 0.028 DBMET00630 0.172 0.02 DBMET02964 | DBMET02964 | |
| 0.06 | 0.347 | 0.189 | GABA C receptor rho-2 antagonist | 0.189 0.036 DBMET00630 0.149 0.075 DBMET02964 | DBMET00630 | |
| 0.005 | 0.293 | 0.2 | Ribonucleoside-diphosphate reductase inhibitor | 0.2 0.007 DBMET01010 0.153 0.011 DBMET02965 0.053 0.039 DBMET00771 0.194 0.007 DBMET00769 0.149 0.011 DBMET02967 0.135 0.013 DBMET01007 | DBMET01010 | |
| 0.017 | 0.305 | 0.105 | Leucine-rich repeat kinase 2 inhibitor | 0.105 0.04 DBMET02964 | DBMET02964 | |
| 0.005 | 0.295 | 0.368 | Ribonucleotide reductase inhibitor | 0.266 0.005 DBMET01010 0.193 0.008 DBMET02965 0.071 0.03 DBMET00771 0.368 0.003 DBMET00769 0.059 0.037 DBMET02966 0.271 0.005 DBMET02967 0.185 0.008 DBMET01007 | DBMET00769 | |
| 0.017 | 0.308 | 0.062 | Carbonic anhydrase stimulant | 0.062 0.039 DBMET00630 0.056 0.045 DBMET02964 | DBMET00630 | |
| 0.014 | 0.306 | 0.07 | Syk tyrosine kinase inhibitor | 0.061 0.058 DBMET00630 0.07 0.05 DBMET02964 | DBMET02964 | |
| 0.023 | 0.315 | 0.342 | Glycogen synthase kinase-3 beta inhibitor | 0.342 0.01 DBMET00630 | DBMET00630 | |
| 0.024 | 0.325 | 0.142 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.029 DBMET02964 0.073 0.024 DBMET02965 0.099 0.007 DBMET00769 0.142 0.004 DBMET02967 | DBMET02967 | |
| 0.047 | 0.35 | 0.194 | MAP kinase kinase 2 inhibitor | 0.152 0.12 DBMET00630 0.194 0.085 DBMET02964 | DBMET02964 | |
| 0.006 | 0.313 | 0.098 | Guanylate cyclase inhibitor | 0.084 0.002 DBMET01010 0.08 0.003 DBMET02965 0.098 0.001 DBMET00769 0.093 0.001 DBMET02967 0.065 0.008 DBMET01007 | DBMET00769 | |
| 0.017 | 0.327 | 0.212 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.152 0.018 DBMET01010 0.122 0.028 DBMET02965 0.212 0.008 DBMET00769 0.169 0.014 DBMET02967 | DBMET00769 | |
| 0.033 | 0.352 | 0.174 | Triose-phosphate isomerase inhibitor | 0.09 0.059 DBMET00630 0.133 0.026 DBMET01010 0.174 0.015 DBMET02965 0.083 0.07 DBMET00769 0.105 0.043 DBMET02967 | DBMET02965 | |
| 0.022 | 0.343 | 0.119 | Antiviral (Hepatitis D) | 0.119 0.004 DBMET00769 0.118 0.004 DBMET02967 0.08 0.009 DBMET01007 | DBMET00769 | |
| 0.023 | 0.345 | 0.109 | Glycogen synthase kinase-3 alpha inhibitor | 0.109 0.095 DBMET02964 | DBMET02964 | |
| 0.102 | 0.425 | 0.206 | Nitric-oxide synthase stimulant | 0.206 0.079 DBMET00630 0.202 0.086 DBMET02964 | DBMET00630 | |
| 0.013 | 0.338 | 0.104 | Alpha adrenoreceptor agonist | 0.104 0.026 DBMET02964 | DBMET02964 | |
| 0.061 | 0.391 | 0.191 | CF transmembrane conductance regulator agonist | 0.151 0.075 DBMET00630 0.191 0.027 DBMET02964 | DBMET02964 | |
| 0.003 | 0.333 | 0.05 | Alpha 2a adrenoreceptor agonist | 0.05 0.004 DBMET02964 | DBMET02964 | |
| 0.003 | 0.335 | 0.255 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.255 0.002 DBMET01010 0.234 0.002 DBMET02965 0.037 0.005 DBMET00771 0.217 0.002 DBMET00769 0.022 0.012 DBMET02966 0.199 0.002 DBMET02967 0.059 0.004 DBMET01007 | DBMET01010 | |
| 0.05 | 0.384 | 0.353 | Transcription factor STAT6 inhibitor | 0.138 0.034 DBMET01010 0.31 0.004 DBMET02965 0.154 0.02 DBMET00769 0.353 0.003 DBMET02967 | DBMET02967 | |
| 0.07 | 0.404 | 0.18 | Superoxide dismutase inhibitor | 0.18 0.141 DBMET00630 | DBMET00630 | |
| 0.075 | 0.412 | 0.144 | Death-associated protein kinase 2 inhibitor | 0.144 0.121 DBMET00630 | DBMET00630 | |
| 0.022 | 0.36 | 0.071 | Interferon inducer | 0.071 0.034 DBMET01009 | DBMET01009 | |
| 0.019 | 0.359 | 0.094 | Cyclin-dependent kinase 2 inhibitor | 0.094 0.077 DBMET02964 | DBMET02964 | |
| 0.082 | 0.422 | 0.794 | Vasodilator, peripheral | 0.283 0.106 DBMET01010 0.418 0.05 DBMET02965 0.709 0.005 DBMET00769 0.794 0.004 DBMET02967 | DBMET02967 | |
| 0.044 | 0.385 | 0.264 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.264 0.074 DBMET01009 | DBMET01009 | |
| 0.037 | 0.378 | 0.198 | I kappa B kinase epsilon inhibitor | 0.198 0.073 DBMET00630 0.194 0.076 DBMET02964 | DBMET00630 | |
| 0.006 | 0.349 | 0.281 | Phosphodiesterase II inhibitor | 0.281 0.004 DBMET01009 0.056 0.037 DBMET01010 0.06 0.032 DBMET02965 | DBMET01009 | |
| 0.101 | 0.446 | 0.221 | Tyrosine 3 hydroxylase inhibitor | 0.19 0.154 DBMET00630 0.221 0.102 DBMET02964 | DBMET02964 | |
| 0.018 | 0.366 | 0.072 | ALK inhibitor | 0.072 0.071 DBMET00630 | DBMET00630 | |
| 0.03 | 0.379 | 0.483 | DNA directed RNA polymerase inhibitor | 0.082 0.081 DBMET00630 0.213 0.012 DBMET01010 0.258 0.009 DBMET02965 0.426 0.005 DBMET00769 0.083 0.079 DBMET02966 0.483 0.004 DBMET02967 0.27 0.008 DBMET01007 | DBMET02967 | |
| 0.013 | 0.369 | 0.106 | Platelet activating factor beta antagonist | 0.106 0.059 DBMET00630 | DBMET00630 | |
| 0.009 | 0.366 | 0.067 | Alpha 1 adrenoreceptor agonist | 0.067 0.03 DBMET02964 | DBMET02964 | |
| 0.027 | 0.385 | 0.437 | Phosphodiesterase inhibitor | 0.437 0.005 DBMET01009 | DBMET01009 | |
| 0.024 | 0.384 | 0.157 | GABA C receptor antagonist | 0.157 0.027 DBMET00630 0.121 0.051 DBMET02964 | DBMET00630 | |
| 0.015 | 0.376 | 0.08 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 DBMET01010 0.075 0.01 DBMET02965 0.057 0.021 DBMET00769 0.053 0.025 DBMET02967 | DBMET01010 | |
| 0.057 | 0.418 | 0.372 | Alpha-glucosidase inhibitor | 0.372 0.126 DBMET01009 | DBMET01009 | |
| 0.038 | 0.411 | 0.146 | MAP3K9 inhibitor | 0.146 0.065 DBMET00630 0.139 0.078 DBMET02964 | DBMET00630 | |
| 0.029 | 0.404 | 0.14 | Alpha-N-acetylglucosaminidase inhibitor | 0.14 0.061 DBMET00630 0.118 0.08 DBMET01009 0.123 0.075 DBMET02964 | DBMET00630 | |
| 0.007 | 0.382 | 0.27 | Phosphodiesterase 2A inhibitor | 0.27 0.004 DBMET01009 0.049 0.035 DBMET01010 0.053 0.03 DBMET02965 | DBMET01009 | |
| 0.048 | 0.43 | 0.193 | Polo-like kinase-3 inhibitor | 0.193 0.049 DBMET00630 | DBMET00630 | |
| 0.012 | 0.401 | 0.92 | Phosphodiesterase III inhibitor | 0.104 0.021 DBMET00630 0.92 0.001 DBMET01009 0.102 0.022 DBMET02964 0.135 0.012 DBMET01010 0.125 0.014 DBMET02965 0.116 0.016 DBMET00771 | DBMET01009 | |
| 0.049 | 0.442 | 0.163 | Adenylate cyclase stimulant | 0.139 0.084 DBMET00630 0.135 0.091 DBMET02964 0.161 0.046 DBMET01010 0.163 0.044 DBMET02965 0.153 0.057 DBMET00769 0.155 0.055 DBMET02967 | DBMET02965 | |
| 0.015 | 0.419 | 0.269 | Phosphodiesterase 3A inhibitor | 0.269 0.005 DBMET01009 | DBMET01009 | |
| 0.04 | 0.445 | 0.218 | Aurora-C kinase inhibitor | 0.142 0.062 DBMET00630 0.218 0.015 DBMET02964 | DBMET02964 | |
| 0.004 | 0.41 | 0.228 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.141 0.002 DBMET01010 0.137 0.002 DBMET02965 0.06 0.004 DBMET00771 0.228 0.002 DBMET00769 0.059 0.004 DBMET02966 0.221 0.002 DBMET02967 0.073 0.003 DBMET01007 | DBMET00769 | |
| 0.027 | 0.439 | 0.353 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.321 0.005 DBMET01010 0.302 0.006 DBMET02965 0.353 0.004 DBMET00769 0.334 0.005 DBMET02967 0.084 0.075 DBMET01007 | DBMET00769 | |
| 0.005 | 0.421 | 0.39 | Inosine monophosphate dehydrogenase inhibitor | 0.366 0.002 DBMET01010 0.39 0.002 DBMET02965 0.052 0.014 DBMET00771 0.309 0.002 DBMET00769 0.032 0.031 DBMET02966 0.326 0.002 DBMET02967 0.099 0.005 DBMET01007 | DBMET02965 | |
| 0.005 | 0.426 | 0.919 | Phosphodiesterase 3B inhibitor | 0.919 0.001 DBMET01009 0.042 0.033 DBMET02964 0.313 0.004 DBMET01010 0.28 0.004 DBMET02965 0.299 0.004 DBMET00771 | DBMET01009 | |
| 0.017 | 0.44 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.042 DBMET02964 | DBMET02964 | |
| 0.017 | 0.443 | 0.131 | CDC-like kinase 2 inhibitor | 0.131 0.109 DBMET02964 | DBMET02964 | |
| 0.019 | 0.445 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.058 DBMET00630 | DBMET00630 | |
| 0.065 | 0.496 | 0.166 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.155 DBMET00630 | DBMET00630 | |
| 0.048 | 0.481 | 0.169 | Focal adhesion kinase 2 inhibitor | 0.158 0.118 DBMET00630 0.169 0.102 DBMET02964 | DBMET02964 | |
| 0.044 | 0.478 | 0.109 | Folate antagonist | 0.109 0.051 DBMET02966 | DBMET02966 | |
| 0.01 | 0.445 | 0.207 | Purinergic P2Y2 antagonist | 0.097 0.004 DBMET00630 0.143 0.003 DBMET01010 0.143 0.003 DBMET02965 0.062 0.007 DBMET00771 0.207 0.002 DBMET00769 0.059 0.008 DBMET02966 0.205 0.002 DBMET02967 0.148 0.003 DBMET01007 | DBMET00769 | |
| 0.077 | 0.514 | 0.269 | Calcium channel activator | 0.269 0.125 DBMET02964 0.212 0.196 DBMET02967 | DBMET02964 | |
| 0.018 | 0.458 | 0.075 | AXL receptor tyrosine kinase inhibitor | 0.075 0.068 DBMET00630 | DBMET00630 | |
| 0.009 | 0.453 | 0.04 | MAP3K5 inhibitor | 0.038 0.029 DBMET00630 0.04 0.026 DBMET02964 | DBMET02964 | |
| 0.019 | 0.469 | 0.684 | Aminoacyl-tRNA synthetase inhibitor | 0.484 0.003 DBMET01010 0.427 0.004 DBMET02965 0.314 0.006 DBMET00771 0.684 0.002 DBMET00769 0.339 0.005 DBMET02966 0.652 0.002 DBMET02967 0.416 0.004 DBMET01007 | DBMET00769 | |
| 0.03 | 0.482 | 0.121 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 DBMET02964 | DBMET02964 | |
| 0.021 | 0.473 | 0.145 | Anabolic | 0.103 0.059 DBMET01010 0.145 0.021 DBMET00769 0.124 0.036 DBMET02967 | DBMET00769 | |
| 0.011 | 0.472 | 0.146 | Protein kinase A inhibitor | 0.104 0.042 DBMET00630 0.146 0.025 DBMET02964 | DBMET02964 | |
| 0.012 | 0.474 | 0.595 | Purinergic P2X4 antagonist | 0.125 0.004 DBMET01010 0.168 0.004 DBMET02965 0.503 0.002 DBMET00769 0.595 0.002 DBMET02967 0.069 0.01 DBMET01007 | DBMET02967 | |
| 0.011 | 0.48 | 0.066 | Cytokine production stimulant | 0.066 0.009 DBMET01009 0.049 0.031 DBMET01010 0.061 0.012 DBMET02966 | DBMET01009 | |
| 0.095 | 0.565 | 0.253 | 5 Hydroxytryptamine uptake stimulant | 0.253 0.078 DBMET02964 | DBMET02964 | |
| 0.034 | 0.505 | 0.139 | Succinate dehydrogenase inhibitor | 0.139 0.134 DBMET01009 | DBMET01009 | |
| 0.002 | 0.474 | 0.073 | Uridine phosphorylase inhibitor | 0.073 0.004 DBMET01010 0.07 0.004 DBMET02965 | DBMET01010 | |
| 0.037 | 0.516 | 0.193 | Interleukin agonist | 0.193 0.127 DBMET00630 0.189 0.131 DBMET01010 0.167 0.151 DBMET02965 | DBMET00630 | |
| 0.004 | 0.491 | 0.195 | Purinergic P2Y1 antagonist | 0.141 0.002 DBMET01010 0.148 0.002 DBMET02965 0.023 0.007 DBMET00771 0.191 0.002 DBMET00769 0.021 0.008 DBMET02966 0.195 0.002 DBMET02967 0.058 0.004 DBMET01007 | DBMET02967 | |
| 0.052 | 0.547 | 0.204 | Histamine release inhibitor | 0.204 0.197 DBMET02964 | DBMET02964 | |
| 0.022 | 0.518 | 0.303 | Mannose-6-phosphate isomerase inhibitor | 0.148 0.066 DBMET01009 0.303 0.005 DBMET01010 0.181 0.042 DBMET02965 0.126 0.091 DBMET00769 | DBMET01010 | |
| 0.022 | 0.532 | 0.269 | Beta lactamase inhibitor | 0.269 0.148 DBMET01009 | DBMET01009 | |
| 0.02 | 0.535 | 0.703 | Immunostimulant | 0.318 0.074 DBMET01009 0.703 0.008 DBMET01010 0.628 0.014 DBMET02965 0.552 0.022 DBMET00771 0.659 0.011 DBMET00769 0.567 0.021 DBMET02966 0.579 0.019 DBMET02967 0.571 0.02 DBMET01007 | DBMET01010 | |
| 0.004 | 0.529 | 0.853 | Purinergic P2Y antagonist | 0.057 0.021 DBMET01009 0.571 0.001 DBMET01010 0.778 0.001 DBMET02965 0.172 0.005 DBMET00771 0.632 0.001 DBMET00769 0.048 0.028 DBMET02966 0.853 0.001 DBMET02967 0.122 0.007 DBMET01007 | DBMET02967 | |
| 0.027 | 0.562 | 0.179 | Peroxidase inhibitor | 0.179 0.066 DBMET00630 0.149 0.078 DBMET01009 | DBMET00630 | |
| 0.027 | 0.561 | 0.391 | DNA polymerase beta inhibitor | 0.391 0.123 DBMET01009 | DBMET01009 | |
| 0.008 | 0.542 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 DBMET00630 0.07 0.046 DBMET01009 0.071 0.046 DBMET02964 | DBMET02964 | |
| 0.009 | 0.546 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.081 0.019 DBMET01010 0.085 0.018 DBMET02965 0.064 0.028 DBMET00771 0.069 0.025 DBMET00769 0.051 0.038 DBMET02966 0.073 0.023 DBMET02967 | DBMET02965 | |
| 0.004 | 0.541 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.045 DBMET01010 0.075 0.028 DBMET00769 0.059 0.04 DBMET02967 | DBMET00769 | |
| 0.025 | 0.568 | 0.384 | Streptokinase A inhibitor | 0.384 0.051 DBMET01009 | DBMET01009 | |
| 0.011 | 0.559 | 0.065 | Phospholipase D inhibitor | 0.065 0.064 DBMET01009 | DBMET01009 | |
| 0.032 | 0.585 | 0.228 | DNA damaging | 0.228 0.094 DBMET01010 0.176 0.139 DBMET00769 | DBMET01010 | |
| 0.007 | 0.561 | 0.063 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET01010 | DBMET01010 | |
| 0.009 | 0.572 | 0.219 | Nicotinic acid receptor 1 agonist | 0.219 0.004 DBMET01007 | DBMET01007 | |
| 0.008 | 0.576 | 0.584 | Expectorant | 0.257 0.012 DBMET01010 0.181 0.025 DBMET02965 0.584 0.003 DBMET00769 0.466 0.004 DBMET02967 0.281 0.01 DBMET01007 | DBMET00769 | |
| 0.011 | 0.583 | 0.343 | Mucolytic | 0.163 0.025 DBMET01010 0.117 0.057 DBMET02965 0.343 0.004 DBMET00769 0.252 0.006 DBMET02967 0.196 0.014 DBMET01007 | DBMET00769 | |
| 0.013 | 0.589 | 0.624 | Pyruvate kinase inhibitor | 0.388 0.023 DBMET01010 0.258 0.059 DBMET02965 0.624 0.004 DBMET00769 0.511 0.008 DBMET02967 0.175 0.097 DBMET01007 | DBMET00769 | |
| 0.017 | 0.599 | 0.268 | Acetylcholine M1 receptor antagonist | 0.116 0.114 DBMET02965 0.211 0.038 DBMET00769 0.268 0.021 DBMET02967 | DBMET02967 | |
| 0 | 0.586 | 0.158 | Purinergic P2Y4 agonist | 0.013 0.001 DBMET01010 0.014 0.001 DBMET02965 0.158 0 DBMET00769 0.156 0 DBMET02967 0.024 0.001 DBMET01007 | DBMET00769 | |
| 0.018 | 0.604 | 0.136 | Protein kinase stimulant | 0.136 0.078 DBMET01010 | DBMET01010 | |
| 0.018 | 0.607 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 DBMET01009 | DBMET01009 | |
| 0.004 | 0.594 | 0.352 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET02965 0.15 0.004 DBMET00769 0.352 0.003 DBMET02967 | DBMET02967 | |
| 0.044 | 0.638 | 0.276 | Insulysin inhibitor | 0.244 0.102 DBMET00630 0.19 0.173 DBMET01009 0.276 0.074 DBMET02964 | DBMET02964 | |
| 0.003 | 0.604 | 0.422 | Phosphorylase inhibitor | 0.213 0.005 DBMET01010 0.147 0.007 DBMET02965 0.422 0.003 DBMET00769 0.302 0.003 DBMET02967 0.075 0.018 DBMET01007 | DBMET00769 | |
| 0.057 | 0.658 | 0.282 | 5 Hydroxytryptamine release inhibitor | 0.256 0.22 DBMET00630 0.282 0.187 DBMET02964 | DBMET02964 | |
| 0.033 | 0.637 | 0.277 | Transcription factor STAT inhibitor | 0.194 0.147 DBMET02964 0.241 0.093 DBMET02965 0.277 0.07 DBMET02967 | DBMET02967 | |
| 0.073 | 0.678 | 0.267 | Peptidyltransferase inhibitor | 0.226 0.07 DBMET01010 0.267 0.04 DBMET02965 0.231 0.066 DBMET00771 0.198 0.101 DBMET00769 0.232 0.065 DBMET02966 0.243 0.056 DBMET02967 | DBMET02965 | |
| 0.003 | 0.615 | 0.457 | HCV NS5B polymerase inhibitor | 0.062 0.008 DBMET02965 0.219 0.004 DBMET00769 0.457 0.002 DBMET02967 0.059 0.008 DBMET01007 | DBMET02967 | |
| 0.059 | 0.678 | 0.452 | Caspase 9 stimulant | 0.324 0.168 DBMET01010 0.452 0.082 DBMET02965 0.296 0.198 DBMET02967 | DBMET02965 | |
| 0.025 | 0.647 | 0.477 | 15-Lipoxygenase inhibitor | 0.316 0.121 DBMET00630 0.477 0.046 DBMET01009 | DBMET01009 | |
| 0.012 | 0.635 | 0.159 | Uric acid excretion stimulant | 0.131 0.032 DBMET00630 0.159 0.02 DBMET01009 0.082 0.08 DBMET02964 | DBMET01009 | |
| 0.007 | 0.64 | 0.153 | Diuretic | 0.153 0.075 DBMET02964 | DBMET02964 | |
| 0.026 | 0.666 | 0.589 | Phospholipase C inhibitor | 0.589 0.004 DBMET01010 0.497 0.006 DBMET02965 0.518 0.005 DBMET00771 0.429 0.009 DBMET00769 0.541 0.005 DBMET02966 0.328 0.016 DBMET02967 0.137 0.135 DBMET01007 | DBMET01010 | |
| 0.04 | 0.683 | 0.431 | MAP kinase 1 inhibitor | 0.431 0.088 DBMET01009 | DBMET01009 | |
| 0.007 | 0.651 | 0.391 | Platelet activating factor antagonist | 0.391 0.005 DBMET02964 | DBMET02964 | |
| 0.027 | 0.672 | 0.626 | Hexokinase inhibitor | 0.381 0.005 DBMET01010 0.392 0.004 DBMET02965 0.132 0.102 DBMET00771 0.612 0.002 DBMET00769 0.141 0.089 DBMET02966 0.626 0.002 DBMET02967 0.216 0.027 DBMET01007 | DBMET02967 | |
| 0.009 | 0.655 | 0.075 | Acetyl-CoA transferase 2 inhibitor | 0.075 0.014 DBMET02964 | DBMET02964 | |
| 0.02 | 0.671 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 DBMET00630 | DBMET00630 | |
| 0.005 | 0.657 | 0.417 | HIV-1 reverse transcriptase inhibitor | 0.158 0.013 DBMET01009 0.155 0.013 DBMET02964 0.216 0.009 DBMET01010 0.151 0.014 DBMET02965 0.093 0.034 DBMET00771 0.417 0.004 DBMET00769 0.354 0.005 DBMET02967 0.243 0.007 DBMET01007 | DBMET00769 | |
| 0.017 | 0.67 | 0.425 | Vasodilator | 0.28 0.055 DBMET01010 0.294 0.05 DBMET02965 0.415 0.021 DBMET00769 0.425 0.019 DBMET02967 | DBMET02967 | |
| 0.003 | 0.659 | 0.052 | Calcitonin gene-related peptide antagonist | 0.052 0.01 DBMET01009 | DBMET01009 | |
| 0.01 | 0.699 | 0.577 | Dual specificity phosphatase 3 inhibitor | 0.577 0.005 DBMET01009 0.127 0.119 DBMET01010 | DBMET01009 | |
| 0.059 | 0.748 | 0.412 | Interleukin 2 agonist | 0.412 0.024 DBMET00630 | DBMET00630 | |
| 0.016 | 0.755 | 0.068 | Gonadotropin-releasing hormone receptor agonist | 0.068 0.028 DBMET02964 | DBMET02964 | |
| 0.003 | 0.754 | 0.414 | Purinergic P2Y12 antagonist | 0.35 0.003 DBMET01009 0.38 0.003 DBMET01010 0.414 0.003 DBMET02965 0.15 0.004 DBMET00771 0.363 0.003 DBMET00769 0.027 0.014 DBMET02966 0.388 0.003 DBMET02967 0.09 0.004 DBMET01007 | DBMET02965 | |
| 0.007 | 0.76 | 0.304 | Purinergic P2X2 antagonist | 0.228 0.004 DBMET01010 0.232 0.003 DBMET02965 0.149 0.012 DBMET00771 0.302 0.002 DBMET00769 0.194 0.005 DBMET02966 0.304 0.002 DBMET02967 0.228 0.004 DBMET01007 | DBMET02967 | |
| 0.008 | 0.761 | 0.095 | AMP-activated protein kinase stimulant | 0.095 0.077 DBMET02965 | DBMET02965 | |
| 0.013 | 0.766 | 0.471 | Antithrombotic | 0.391 0.052 DBMET01010 0.471 0.034 DBMET02965 0.368 0.058 DBMET00769 0.45 0.038 DBMET02967 0.213 0.162 DBMET01007 | DBMET02965 | |
| 0.011 | 0.79 | 0.138 | Hemostatic | 0.138 0.084 DBMET02964 | DBMET02964 | |
| 0.004 | 0.786 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.027 DBMET02964 | DBMET02964 | |
| 0.009 | 0.805 | 0.505 | Dual specificity phosphatase inhibitor | 0.505 0.006 DBMET01009 | DBMET01009 | |
| 0.005 | 0.809 | 0.176 | M17 leucyl aminopeptidase inhibitor | 0.176 0.042 DBMET00771 0.161 0.049 DBMET02966 | DBMET00771 | |
| 0.002 | 0.811 | 0.059 | Calcitonin gene-related peptide 1 receptor antagonist | 0.059 0.005 DBMET01009 | DBMET01009 | |
| 0.018 | 0.855 | 0.1 | Hematopoietic | 0.1 0.036 DBMET01010 0.1 0.036 DBMET02965 | DBMET02965 | |
| 0.005 | 0.845 | 0.469 | Cyclophilin A inhibitor | 0.469 0.001 DBMET02964 | DBMET02964 | |
| 0.004 | 0.847 | 0.214 | Lipoxygenase inhibitor | 0.214 0.126 DBMET01009 | DBMET01009 | |
| 0.005 | 0.85 | 0.135 | Interleukin antagonist | 0.135 0.13 DBMET01009 | DBMET01009 | |
| 0.006 | 0.876 | 0.042 | Antibiotic Aminoglycoside-like | 0.04 0.021 DBMET01010 0.042 0.019 DBMET02965 0.038 0.023 DBMET00769 0.041 0.02 DBMET02967 | DBMET02965 | |
| 0.005 | 0.884 | 0.435 | Platelet aggregation inhibitor | 0.435 0.015 DBMET02964 | DBMET02964 | |
| 0.007 | 0.908 | 0.141 | Angiogenesis stimulant | 0.141 0.129 DBMET01010 0.14 0.129 DBMET02965 | DBMET01010 | |
| 0.005 | 0.941 | 0.036 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET01010 0.036 0.007 DBMET02965 0.03 0.012 DBMET00769 0.03 0.011 DBMET02967 0.026 0.019 DBMET01007 | DBMET02965 | |
| 0.024 | 0.966 | 0.112 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.073 DBMET01010 0.112 0.07 DBMET02965 | DBMET02965 | |
| 0.003 | 0.95 | 0.09 | Glutamate (mGluR) agonist | 0.069 0.037 DBMET00771 0.09 0.026 DBMET02966 | DBMET02966 | |
| 0.007 | 0.953 | 0.138 | Interleukin 6 antagonist | 0.138 0.109 DBMET02965 | DBMET02965 | |
| 0.002 | 0.957 | 0.448 | Purinergic P2T antagonist | 0.161 0.004 DBMET01010 0.171 0.004 DBMET02965 0.079 0.006 DBMET00771 0.445 0.003 DBMET00769 0.053 0.009 DBMET02966 0.448 0.003 DBMET02967 0.145 0.004 DBMET01007 | DBMET02967 | |
| 0.005 | 0.96 | 0.282 | Bone formation stimulant | 0.282 0.019 DBMET00771 0.28 0.02 DBMET02966 | DBMET00771 | |
| 0.005 | 0.97 | 0.32 | Cardiotonic | 0.191 0.128 DBMET02965 0.32 0.048 DBMET02967 | DBMET02967 | |
| 0.003 | 0.97 | 0.064 | Purinergic P2X3 antagonist | 0.045 0.013 DBMET00769 0.064 0.007 DBMET02967 | DBMET02967 | |
| 0.012 | 0.98 | 0.169 | Transcription factor NF kappa B stimulant | 0.126 0.023 DBMET01010 0.125 0.023 DBMET02965 0.169 0.013 DBMET00769 0.167 0.013 DBMET02967 0.104 0.035 DBMET01007 | DBMET00769 | |
| 0.009 | 0.977 | 0.141 | Interleukin 5 antagonist | 0.141 0.014 DBMET01009 | DBMET01009 | |
| 0.003 | 0.976 | 0.377 | Purinergic P2 antagonist | 0.058 0.05 DBMET01009 0.318 0.004 DBMET01010 0.361 0.004 DBMET02965 0.338 0.004 DBMET00769 0.377 0.004 DBMET02967 0.133 0.013 DBMET01007 | DBMET02967 | |
| 0.004 | 0.978 | 0.319 | Platelet antagonist | 0.174 0.122 DBMET02965 0.271 0.064 DBMET00769 0.319 0.047 DBMET02967 0.252 0.071 DBMET01007 | DBMET02967 | |
| 0.005 | 0.983 | 0.726 | Cyclophilin D inhibitor | 0.726 0.012 DBMET00771 0.684 0.016 DBMET02966 | DBMET00771 | |
| 0.004 | 0.985 | 0.201 | Cyclooxygenase 1 inhibitor | 0.201 0.034 DBMET00630 | DBMET00630 | |
| 0.001 | 0.984 | 0.028 | Progesterone agonist | 0.028 0.007 DBMET01009 | DBMET01009 | |
| 0.004 | 0.989 | 0.076 | Autotaxin inhibitor | 0.076 0.02 DBMET00771 0.053 0.036 DBMET02966 | DBMET00771 | |
| 0.007 | 0.992 | 0.357 | Interleukin 4 antagonist | 0.357 0.005 DBMET01009 | DBMET01009 | |
| 0.002 | 0.989 | 0.102 | HIV-1 integrase (3'-Processing) inhibitor | 0.102 0.025 DBMET01010 | DBMET01010 | |
| 0.002 | 0.99 | 0.099 | HIV-1 integrase (Strand Transfer) inhibitor | 0.099 0.023 DBMET01010 | DBMET01010 | |
| 0.002 | 0.992 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.029 DBMET01010 | DBMET01010 | |
| 0.004 | 0.995 | 0.167 | Hepatoprotectant | 0.139 0.122 DBMET01010 0.167 0.093 DBMET00769 0.146 0.114 DBMET02967 | DBMET00769 | |
| 0.006 | 0.996 | 0.167 | Heme oxygenase stimulant | 0.167 0.002 DBMET01009 0.087 0.011 DBMET01010 0.086 0.012 DBMET02965 0.089 0.01 DBMET00771 | DBMET01009 | |
| 0.004 | 0.995 | 0.212 | Platelet adhesion inhibitor | 0.156 0.099 DBMET01010 0.212 0.065 DBMET02965 0.154 0.101 DBMET00769 0.208 0.067 DBMET02967 | DBMET02965 | |
| 0.004 | 0.995 | 0.318 | Insulin secretagoues | 0.185 0.044 DBMET02965 0.215 0.029 DBMET00769 0.318 0.01 DBMET02967 0.138 0.088 DBMET01007 | DBMET02967 | |
| 0.004 | 0.996 | 0.067 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DBMET01010 0.067 0.018 DBMET02965 0.058 0.031 DBMET00769 0.061 0.026 DBMET02967 | DBMET02965 | |
| 0.003 | 0.995 | 0.193 | Protein-tyrosine phosphatase inhibitor | 0.184 0.054 DBMET00771 0.193 0.05 DBMET02966 | DBMET02966 | |
| 0.002 | 0.995 | 0.052 | Endothelin-converting enzyme inhibitor | 0.045 0.034 DBMET00771 0.041 0.037 DBMET02966 0.052 0.029 DBMET01007 | DBMET01007 | |
| 0.001 | 0.995 | 0.05 | Sphingosine 1-phosphate receptor 3 agonist | 0.047 0.017 DBMET01010 0.05 0.016 DBMET02965 | DBMET02965 | |
| 0.001 | 0.996 | 0.037 | Elastase 2A inhibitor | 0.037 0.007 DBMET02964 | DBMET02964 | |
| 0.001 | 0.996 | 0.037 | Elastase 2 inhibitor | 0.037 0.007 DBMET02964 | DBMET02964 | |
| 0 | 1 | 0.014 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 DBMET01010 0.014 0.003 DBMET02965 0.008 0.006 DBMET00769 0.008 0.006 DBMET02967 | DBMET02965 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |